MAP2 was shown to be overexpressed in cutaneous melanoma [67] and is considered a specific marker for pulmonary carcinoid tumor and small-cell carcinoma [68]; however, its biological function in cervical cancer tumorigenesis is poorly understood. This evidence concerns the gene MAP2 and lung carcinoid tumor.